Your trusted destination for CME, CPD & Medical Education across the Middle East.
Inova Health System, Falls Church, Virginia, USA
Prof. Zobair M. Younossi, MD, MPH, is a world-renowned hepatologist, Professor, and Chairman of the Beatty Liver and Obesity Research Program at Inova Health System in Virginia, USA. He earned his MD from Rochester, completed gastroenterology fellowship training at Scripps Clinic, and holds a Master’s in Public Health. He serves as Chairman of the Global NASH/MASH Council.
Prof. Younossi is an internationally acclaimed researcher who has published over 600 peer-reviewed articles on non-alcoholic fatty liver disease (MASLD/MASH), health-related quality of life, and liver disease epidemiology, shaping global clinical practice guidelines.
Prof. Zobair M. Younossi is an internationally recognized hepatologist, academic physician, and clinical researcher whose work has significantly contributed to the understanding and treatment of chronic liver diseases. He is Professor of Medicine and Chairman of the Global Center for Liver Outcomes & Policy Research at Georgetown University School of Medicine in Washington, DC. He also serves as Chairman of the Global NASH/MASH Council and President of the Chronic Liver Disease Foundation.
Prof. Younossi earned his medical degree from the University of Rochester School of Medicine and Dentistry in 1989, where he was inducted into the Alpha Omega Alpha Honor Medical Society. He completed his residency in Internal Medicine and fellowship training in Gastroenterology and Hepatology at the Scripps Clinic and Research Foundation in California. During his postgraduate training, he also obtained a Master of Public Health degree from San Diego State University in 1995, receiving the Hanlon Award and Outstanding Student Award.
He began his academic and research career at the Cleveland Clinic Foundation, where he worked as a Staff Hepatologist and Senior Researcher from 1995 to 2000. In 2000, he joined Inova Health System in Virginia and established its Center for Liver Diseases and the Beatty Liver and Obesity Research Program. During his more than 25 years at Inova, he held several senior leadership positions, including Chairman of the Department of Medicine at Inova Fairfax Medical Campus, President of Inova Medicine, and Vice President for Research.
Prof. Younossi is particularly known for his pioneering research into non-alcoholic fatty liver disease (NAFLD), now commonly discussed within the broader terminology of metabolic dysfunction-associated steatotic liver disease (MASLD), and its progression to more advanced liver conditions. His research encompasses clinical outcomes, health-related quality of life, healthcare economics, epidemiology, and the development of evidence-based approaches to liver disease management.
Prof. Younossi's research focuses on MASLD, formerly known as NAFLD, metabolic dysfunction-associated steatohepatitis (MASH), viral hepatitis, chronic liver disease, and liver-related health outcomes. He has made important contributions to understanding the clinical burden, economic impact, quality-of-life implications, and long-term consequences of metabolic liver disease.
His academic work includes clinical trials, epidemiological studies, systematic reviews, health economics research, and the development of patient-reported outcome measures. He has also contributed to international clinical guidelines and scientific recommendations through collaborations with leading liver and gastroenterology organizations.
Throughout his career, Prof. Younossi has served on editorial boards of major medical journals and held editorial leadership roles, including Co-Editor of Liver International and Associate Editor of the Journal of Hepatology. He has also mentored medical students, residents, fellows, and researchers, helping develop future leaders in hepatology and clinical investigation.

Kuwait Gastroenterology Association (KGA)
Kuwait Gastroenterology Association (KGA)